HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


No Concealing Cosmeceutical Claims From NAD, FTC

This article was originally published in The Tan Sheet

Executive Summary

Claims for cosmeceuticals referred by the National Advertising Division go to the same place on the Federal Trade Commission's list of priorities as other disputed claims - straight to the top

You may also be interested in...

Cosmeceutical Claims May Be Headed Into FDA's Radar

FDA under the Obama administration may cast a sharper eye on cosmeceuticals than the agency has in years past, according to Georgia C. Ravitz, a food and drug law lawyer at Arent Fox

ERSP Refers NVE Pharmaceuticals’ AppuLoss Weight-Loss Ads To FTC

The Electronic Retailing Self-Regulation Program referred advertising for NVE Pharmaceuticals' AppuLoss dietary supplement to the Federal Trade Commission after the firm failed to respond to an inquiry

FTC Fines Oreganol Marketer $2.5 Million After Firm Ignores NAD Inquiry

North American Herb & Spice Co. has agreed to pay a $2.5 million fine to settle a complaint the Federal Trade Commission filed after the firm failed to respond to an inquiry from the National Advertising Division

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts